New developments in the treatment of chronic hepatitis B.

Abstract

Significant progress has been made during the last 2 years in the treatment of chronic hepatitis B (CHB). Treatment decisions differ significantly depending on whether patients are HBeAg+ or HBeAg-, treatment-naive or nucleoside/nucleotide-resistant, and in early or advanced stages of liver disease. Courses of finite duration, aiming to achieve sustained… (More)

Topics

Cite this paper

@article{Hadziyannis2006NewDI, title={New developments in the treatment of chronic hepatitis B.}, author={Stephanos J. Hadziyannis}, journal={Expert opinion on biological therapy}, year={2006}, volume={6 9}, pages={913-21} }